Merck and Ridgeback announce the filing of an emergency filing with the U.S. FDA for molnupiravir, an investigational oral antiviral drug used to treat mild to moderate COVID-19 in at-risk…
Tag: Antiviral
Antiviral compound blocks SARS-CoV-2 from entering cells – Washington University School of Medicine in St. Louis
Visit the news hub New compound could also be effective against other coronaviruses Scientists at Washington University School of Medicine in St. Louis have developed a compound that prevents SARS-CoV-2…
Merck and Ridgeback Announce Submission of Emergency Use Authorization Application to the U.S. FDA for Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of Mild-to-Moderate COVID-19 in At Risk Adults
KENILWORTH, NJ & MIAMI–(GESCHÄFTSDRAHT)–Merck (NYSE: MRK), außerhalb der Vereinigten Staaten und Kanadas als MSD bekannt, und Ridgeback Biotherapeutics gaben heute bekannt, dass Merck bei der US-amerikanischen Food and Drug Administration…